Interim guidance for rapid antigen testing for SARS-CoV-2

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Aug. 29, 2020
  
  Note: Antigen tests can be used in a variety of testing strategies to respond to the coronavirus disease 2019 (COVID-19) pandemic. This interim guidance is intended for clinicians who order antigen tests, receive antigen test results, and/or perform point of care testing, as well as for laboratory professionals who perform antigen testing in a laboratory setting or at the point of care and report those results. The purpose of this interim technical guidance is to support the most effective use of antigen tests for different testing situations. This guidance applies to all uses of antigen tests and is not specific to the application of antigen tests to any particular age group or setting. This guidance supplements and is consistent with CDC’s Overview of Testing for SARS-CoV-2 guidance. CDC has also provided a summary of considerations for using antigen tests in nursing home facilities.
  
  
• Content Notes:
  Definitions of Diagnostic, Screening, and Surveillance Testing for SARS-CoV-2 -- Rapid Antigen Testing for SARS-CoV-2 -- Summary Tables.
• Subjects:
  Antigens, Viral/analysis Clinical Laboratory Techniques Coronavirus Infections/diagnosis COVID-19 Diagnostic Tests, Routine Immunoassay Laboratories
• Document Type:
  Webpage
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:3211cd85774d8d32b764895912a606eb899fd1595ee6254e6f3577b5cd22f615
• Download URL:
  https://stacks.cdc.gov/view/cdc/92731/cdc_92731_DS1.pdf
• File Type:
  [PDF - 229.59 KB ]